ALXN
Point72 Asset Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-200,000
| Closed | -$31.2M | – | 1239 |
|
|
2020
Q4 | $31.2M | Sell |
200,000
-1,166,848
| -85% | -$182M | 0.15% | 177 |
|
|
2020
Q3 | $156M | Buy |
1,366,848
+155,506
| +13% | +$17.8M | 0.8% | 12 |
|
|
2020
Q2 | $136M | Buy |
1,211,342
+568,997
| +89% | +$63.9M | 0.89% | 8 |
|
|
2020
Q1 | $57.7M | Buy |
642,345
+303,832
| +90% | +$27.3M | 0.47% | 44 |
|
|
2019
Q4 | $36.6M | Sell |
338,513
-80,728
| -19% | -$8.73M | 0.19% | 148 |
|
|
2019
Q3 | $41.1M | Buy |
419,241
+375,359
| +855% | +$36.8M | 0.25% | 118 |
|
|
2019
Q2 | $5.75M | Buy |
+43,882
| New | +$5.75M | 0.03% | 420 |
|
|
2019
Q1 | – | Sell |
-770,836
| Closed | -$75M | – | 1186 |
|
|
2018
Q4 | $75M | Buy |
770,836
+44,153
| +6% | +$4.3M | 0.37% | 58 |
|
|
2018
Q3 | $101M | Buy |
726,683
+288,883
| +66% | +$40.2M | 0.42% | 44 |
|
|
2018
Q2 | $54.4M | Buy |
437,800
+352,800
| +415% | +$43.8M | 0.22% | 105 |
|
|
2018
Q1 | $9.47M | Sell |
85,000
-137,737
| -62% | -$15.4M | 0.04% | 361 |
|
|
2017
Q4 | $26.6M | Buy |
222,737
+162,837
| +272% | +$19.5M | 0.12% | 200 |
|
|
2017
Q3 | $8.4M | Sell |
59,900
-362,700
| -86% | -$50.9M | 0.04% | 356 |
|
|
2017
Q2 | $51.4M | Buy |
422,600
+262,700
| +164% | +$32M | 0.29% | 78 |
|
|
2017
Q1 | $19.4M | Sell |
159,900
-238,300
| -60% | -$28.9M | 0.11% | 231 |
|
|
2016
Q4 | $48.7M | Sell |
398,200
-213,300
| -35% | -$26.1M | 0.34% | 70 |
|
|
2016
Q3 | $74.9M | Buy |
611,500
+82,000
| +15% | +$10M | 0.53% | 29 |
|
|
2016
Q2 | $61.8M | Buy |
529,500
+443,800
| +518% | +$51.8M | 0.42% | 41 |
|
|
2016
Q1 | $11.9M | Buy |
+85,700
| New | +$11.9M | 0.09% | 236 |
|
|
2014
Q3 | – | Sell |
-11,700
| Closed | -$1.83M | – | 758 |
|
|
2014
Q2 | $1.83M | Buy |
+11,700
| New | +$1.83M | 0.01% | 528 |
|